A retrospective study of the inpatient treatment of psoriasis with dithranol.
This study reports the results of the Ingram dithranol regimen for the treatment of psoriasis in 275 inpatients. The median duration of hospitalization until clearance was 25 days and the medians of the interval until a next treatment or hospitalization was needed were 11 and 8.5 months, respectively.
De Bersaques
J
J
Department of Dermatology, University of Ghent, Belgium.
D000875:Anthralin / Q000627:therapeutic use*; D006801:Humans; D007902:Length of Stay; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies
D000875:Anthralin